Qube Research & Technologies Ltd - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2023$163,261
-89.8%
42,516
-87.3%
0.00%
-90.0%
Q3 2022$1,603,000
+2814.5%
335,370
+2640.6%
0.01%
Q2 2022$55,000
-6.8%
12,237
+16.8%
0.00%
-100.0%
Q3 2021$59,000
-83.2%
10,476
-80.3%
0.00%
-75.0%
Q2 2021$351,000
-41.9%
53,228
-28.6%
0.00%
-60.0%
Q1 2021$604,000
+310.9%
74,588
+227.0%
0.01%
+400.0%
Q4 2020$147,000
-64.8%
22,811
-74.9%
0.00%
-66.7%
Q2 2020$418,00090,7830.01%
Other shareholders
IMMUNOGEN INC shareholders Q1 2023
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders